KAI-9531
K9531-3104
Phase 3 small_molecule active
Quick answer
KAI-9531 for Obesity With Diabetes is a Phase 3 program (small_molecule) at Kailera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kailera Therapeutics
- Indication
- Obesity With Diabetes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active